Announcement PDF Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. Appendix 3Y Page 1 Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11 Name of entity: ImpediMed Limited ABN: 089 705 144 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Ms Janelle Delaney Date of last notice 21 October 2026 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Direct and Indirect Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. Mr Todd Delaney and Mrs Janelle Delaney as trustee for the Delaney Family Superannuation Fund. Ms Delaney is a trustee and a beneficiary of the superannuation fund. Date of change 27 October 2026 No. of securities held prior to change Direct 1,399,391 Ordinary shares Indirect 12,921,387 Ordinary shares 10,000,000 Attaching Options 10,000,000 Follow-on Options Class Ordinary shares Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. Appendix 3Y Page 2 Number acquired 776,087 Ordinary shares Number disposed Nil Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation $0.0046 per share No. of securities held after change Direct 2,175,478 Ordinary shares Indirect 12,921,387 Ordinary shares 10,000,000 Attaching Options 10,000,000 Follow-on Options Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back Issue of shares in lieu of 15% of non- executive director fees for the quarter ended 30 September 2026 Part 2 – Change of director’s interests in contracts Not applicable. Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. Appendix 3Y Page 3 Part 3 – +Closed period Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? No If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided? Date of Notice: 28 October 2026